IDEXX Laboratories Inc (IDXX)
Debt-to-capital ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 622,883 | 618,813 | 696,844 | 696,362 | 694,387 | 760,814 | 767,995 | 773,381 | 775,205 | 778,025 | 780,079 | 778,747 | 858,492 | 853,316 | 900,300 | 698,000 | 698,910 | 697,200 | 701,100 | 699,800 |
Total stockholders’ equity | US$ in thousands | 1,484,530 | 1,297,410 | 1,093,860 | 841,101 | 608,737 | 475,999 | 457,008 | 639,798 | 689,992 | 754,754 | 747,460 | 702,696 | 632,088 | 440,576 | 272,963 | 107,674 | 177,473 | 202,418 | 171,246 | 51,562 |
Debt-to-capital ratio | 0.30 | 0.32 | 0.39 | 0.45 | 0.53 | 0.62 | 0.63 | 0.55 | 0.53 | 0.51 | 0.51 | 0.53 | 0.58 | 0.66 | 0.77 | 0.87 | 0.80 | 0.77 | 0.80 | 0.93 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $622,883K ÷ ($622,883K + $1,484,530K)
= 0.30
The debt-to-capital ratio of Idexx Laboratories, Inc. has shown a decreasing trend over the past eight quarters, indicating a lower reliance on debt compared to its total capital. In Q4 2023, the debt-to-capital ratio was 0.39, the lowest in the provided data series. This suggests that Idexx Laboratories has been reducing its debt levels relative to its capital base, which can be seen as a positive sign of financial health and stability.
The decreasing trend in the debt-to-capital ratio reflects the company's efforts to manage its debt levels effectively and maintain a strong capital structure. A lower debt-to-capital ratio indicates that a smaller portion of the company's capital structure is financed by debt, which can reduce financial risk and improve the company's ability to weather economic uncertainties or challenges.
Overall, the declining trend in Idexx Laboratories' debt-to-capital ratio indicates a prudent approach to managing its debt levels and maintaining a healthy financial position. Investors and analysts may view this trend positively as it suggests that the company is effectively balancing its debt and equity financing to support its operations and growth initiatives.
Peer comparison
Dec 31, 2023